The global Cephalosporin Drugs Market is anticipated to expand from $12.5 billion in 2023 to $19.1 b
The Cephalosporin Drugs Market encompasses the pharmaceutical segment dedicated to the development, production, and distribution of cephalosporin antibiotics. These drugs, classified into generations based on their antimicrobial properties, are pivotal in treating bacterial infections. The market is driven by rising incidences of infectious diseases, advancements in drug formulations, and the need for effective antibiotic therapies, positioning it as a critical component of global healthcare strategies.